BNTC
Benitec Biopharma·NASDAQ
--
--(--)
--
--(--)
5.26 / 10
Netural
Benitec Biopharma's fundamental score is 5.3/10, indicating moderate quality. Key positives include a strong inventory turnover ratio (126.8281) and a healthy interest-coverage ratio (48.5879%), which support operational efficiency and solvency. However, the stock's PB-ROE is elevated at 2.3614, signaling potential overvaluation relative to peers, and several revenue- and profit-to-market ratios are below par, tempering the overall fundamental outlook. Historical back-tests show mixed returns across factors, reinforcing a guarded stance.
Analysis Checks(9/10)
Revenue-MV
Value-0.26
Score3/3
Weight25.21%
1M Return11.03%
Value-0.26
Score3/3
Weight25.21%
1M Return11.03%
Inventory turnover ratio
Value126.83
Score2/3
Weight-2.10%
1M Return-1.23%
Value126.83
Score2/3
Weight-2.10%
1M Return-1.23%
PB-ROE
Value2.36
Score0/3
Weight7.21%
1M Return3.36%
Value2.36
Score0/3
Weight7.21%
1M Return3.36%
Operating revenue (YoY growth rate %)
Value74.94
Score2/3
Weight0.18%
1M Return0.10%
Value74.94
Score2/3
Weight0.18%
1M Return0.10%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-1.72%
1M Return-0.98%
Value100.00
Score2/3
Weight-1.72%
1M Return-0.98%
Total operating revenue (YoY growth rate %)
Value54.19
Score3/3
Weight1.63%
1M Return0.88%
Value54.19
Score3/3
Weight1.63%
1M Return0.88%
Profit-MV
Value0.47
Score2/3
Weight20.24%
1M Return8.99%
Value0.47
Score2/3
Weight20.24%
1M Return8.99%
Interest coverage ratio (EBIT / Interest expense) (%)
Value48.59
Score2/3
Weight-2.18%
1M Return-1.25%
Value48.59
Score2/3
Weight-2.18%
1M Return-1.25%
Asset-MV
Value-1.79
Score3/3
Weight32.11%
1M Return11.94%
Value-1.79
Score3/3
Weight32.11%
1M Return11.94%
Cash-MV
Value-0.07
Score2/3
Weight19.43%
1M Return8.80%
Value-0.07
Score2/3
Weight19.43%
1M Return8.80%
Revenue-MV
Value-0.26
Score3/3
Weight25.21%
1M Return11.03%
Value-0.26
Score3/3
Weight25.21%
1M Return11.03%
Total operating revenue (YoY growth rate %)
Value54.19
Score3/3
Weight1.63%
1M Return0.88%
Value54.19
Score3/3
Weight1.63%
1M Return0.88%
Inventory turnover ratio
Value126.83
Score2/3
Weight-2.10%
1M Return-1.23%
Value126.83
Score2/3
Weight-2.10%
1M Return-1.23%
Profit-MV
Value0.47
Score2/3
Weight20.24%
1M Return8.99%
Value0.47
Score2/3
Weight20.24%
1M Return8.99%
PB-ROE
Value2.36
Score0/3
Weight7.21%
1M Return3.36%
Value2.36
Score0/3
Weight7.21%
1M Return3.36%
Interest coverage ratio (EBIT / Interest expense) (%)
Value48.59
Score2/3
Weight-2.18%
1M Return-1.25%
Value48.59
Score2/3
Weight-2.18%
1M Return-1.25%
Operating revenue (YoY growth rate %)
Value74.94
Score2/3
Weight0.18%
1M Return0.10%
Value74.94
Score2/3
Weight0.18%
1M Return0.10%
Asset-MV
Value-1.79
Score3/3
Weight32.11%
1M Return11.94%
Value-1.79
Score3/3
Weight32.11%
1M Return11.94%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-1.72%
1M Return-0.98%
Value100.00
Score2/3
Weight-1.72%
1M Return-0.98%
Cash-MV
Value-0.07
Score2/3
Weight19.43%
1M Return8.80%
Value-0.07
Score2/3
Weight19.43%
1M Return8.80%
Is BNTC undervalued or overvalued?
- BNTC scores 5.26/10 on fundamentals and holds a Fair valuation at present. Backed by its -9.39% ROE, 0.00% net margin, -9.93 P/E ratio, 4.44 P/B ratio, and -166.06% earnings growth, these metrics solidify its Netural investment rating.
